138 related articles for article (PubMed ID: 20473734)
1. Short-term effect of combined therapy with Jinlong Capsule and transcatheter arterial chemoembolization on patients with primary hepatic carcinoma and its influence on serum osteopontin expression.
Wu GL; Zhang L; Li TY; Chen J; Yu GY; Li JP
Chin J Integr Med; 2010 Apr; 16(2):109-13. PubMed ID: 20473734
[TBL] [Abstract][Full Text] [Related]
2. Trans-arterial chemoembolization combined with Jinlong capsule for advanced hepatocellular carcinoma: a PRISMA-compliant meta-analysis in a Chinese population.
Jia S; Fu Y; Tao H
Pharm Biol; 2020 Dec; 58(1):771-784. PubMed ID: 32767901
[TBL] [Abstract][Full Text] [Related]
3. [Effects of Jinlong Capsule on expressions of interleukin-2 and soluble interleukin-2 receptor in patients with primary liver cancer after transarterial chemoembolization therapy].
Zhang HJ; Yang JJ; Wang WX; Jiang X; Mao YJ; Yang CA; Guo JX
Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):907-10. PubMed ID: 18782532
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Kim SH; Chung YH; Yang SH; Kim JA; Jang MK; Kim SE; Lee D; Lee SH; Lee D; Kim KM; Lim YS; Lee HC; Lee YS; Suh DJ
Korean J Hepatol; 2009 Sep; 15(3):320-30. PubMed ID: 19783881
[TBL] [Abstract][Full Text] [Related]
5. [Primary hepatocarcinoma treated by traditional Chinese medicine combined with transcatheter arterial chemoembolization].
Hou EC; Lu YX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Mar; 29(3):225-7. PubMed ID: 19548439
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of Jianpi Liqi Fang combined with transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and spleen deficiency syndrome.
Chen X; Wang P; Yang M; Zhou W; Chen J; Meng Z; Su S
J Tradit Chin Med; 2021 Feb; 41(1):157-166. PubMed ID: 33522209
[TBL] [Abstract][Full Text] [Related]
7. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
Yu Y; Lang Q; Chen Z; Li B; Yu C; Zhu D; Zhai X; Ling C
Cancer; 2009 Nov; 115(22):5132-8. PubMed ID: 19672999
[TBL] [Abstract][Full Text] [Related]
8. Treatment of middle/late stage primary hepatic carcinoma by Chinese medicine comprehensive therapy: A prospective randomized controlled study.
Tian HQ; Li HL; Wang B; Liang GW; Huang XQ; Huang ZQ; Lang JM; Zhang YP; Chen XZ; Chen YS
Chin J Integr Med; 2010 Apr; 16(2):102-8. PubMed ID: 20473733
[TBL] [Abstract][Full Text] [Related]
9. Serum TSGF and miR-214 levels in patients with hepatocellular carcinoma and their predictive value for the curative effect of transcatheter arterial chemoembolization.
Tang L; Zhang XM
Ann Palliat Med; 2020 Jul; 9(4):2111-2117. PubMed ID: 32762227
[TBL] [Abstract][Full Text] [Related]
10. Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma.
Zhou B; Yan Z; Liu R; Shi P; Qian S; Qu X; Zhu L; Zhang W; Wang J
Radiology; 2016 Aug; 280(2):630-9. PubMed ID: 26885681
[TBL] [Abstract][Full Text] [Related]
11. [A preliminary clinical study on the treatment of primary hepatic carcinoma by transcatheter arterial perfusion of batroxobin combined with TACE].
Lou MW; Wang H; Gao TJ; Fan Y
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):373-6. PubMed ID: 20723437
[TBL] [Abstract][Full Text] [Related]
12. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
Yuan P; Zhang Z; Kuai J
J BUON; 2019; 24(1):163-170. PubMed ID: 30941966
[TBL] [Abstract][Full Text] [Related]
13. [External radiation and combined transcatheter arterial chemoembolization for unresectable primary liver cancer].
Liu MZ; Wang XS; Cai L; Gu MF; Liu H; Li Q; Cui NJ; Zhang YQ; Li GH; Li JQ
Ai Zheng; 2005 Jan; 24(1):82-6. PubMed ID: 15642207
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome.
Liu W; Xu H; Ying X; Zhang D; Lai L; Wang L; Tu J; Ji J
Med Sci Monit; 2020 Jul; 26():e923263. PubMed ID: 32667906
[TBL] [Abstract][Full Text] [Related]
15. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
Hsieh MY; Lin ZY; Chuang WL
Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of endostar combined with transcatheter arterial chemoembolization and analysis of vascular endothelial factor and C-reactive protein levels in patients with advanced hepatocellular carcinoma under contrast enhanced ultrasound.
Wang Y; Xuan Z; Zheng X; Han R; Zhou L; Liu H; Liu Y
J BUON; 2019; 24(6):2394-2401. PubMed ID: 31983111
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
Xu RC; Liu HC; Li JL; Li K; Ou SY; Yu ZY; Kong Y; Ma GA; Shao WS
Curr Med Res Opin; 2015 Aug; 31(8):1553-60. PubMed ID: 26067770
[TBL] [Abstract][Full Text] [Related]
18. Association between insulin-like growth factor-2 expression and prognosis after transcatheter arterial chemoembolization and octreotide in patients with hepatocellular carcinoma.
Xiong ZP; Huang F; Lu MH
Asian Pac J Cancer Prev; 2012; 13(7):3191-4. PubMed ID: 22994732
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Transarterial Chemoembolization in Combination With Kang'ai Injection on Patients With Intermediate Stage Hepatocellular Carcinoma: A Prospective Study.
Wan YM; Li YH; Xu ZY; Wu HM; Xu Y; Yang M; Wu XN
Integr Cancer Ther; 2018 Jun; 17(2):477-485. PubMed ID: 29108428
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter arterial chemoembolization combined with or without Chinese herbal therapy for hepatocellular carcinoma: meta-analysis.
Cho WC; Chen HY
Expert Opin Investig Drugs; 2009 May; 18(5):617-35. PubMed ID: 19388879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
